Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07238023 · ClinicalTrials.gov registry record · NA
Promoting Active Living Among People With Metastatic Breast Cancer
A NA study of Metastatic Invasive Breast Cancer, sponsored by University of Oklahoma.
- Recruiting
- Registry status
- NA
- Development phase
- 38
- Enrollment target
- 1
- Study location
NCT07238023: Recruiting NA study of Metastatic Invasive Breast Cancer, sponsored by University of Oklahoma.
NCT07238023 is a NA study of Metastatic Invasive Breast Cancer that is actively recruiting participants, run by University of Oklahoma. The registered enrollment target is 38 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07238023, a NA study of Metastatic Invasive Breast Cancer, is actively recruiting participants, sponsored by University of Oklahoma.
- RECRUITING
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
- 1
- Study location
Study Summary
Individuals with metastatic breast cancer are living longer but often face persistent fatigue, functional decline, and psychological distress. Physical activity is generally safe for this population and may alleviate symptom burden. Yet, limited interventions are tailored to the unique and needs and preferences of this population. This study aims to evaluate the acceptability and feasibility of a mindfulness- and acceptance-based physical activity program designed to support mental, social, and spiritual well-being among people with metastatic breast cancer. A single group, pretest-posttest trial (N=38) will be conducted to inform scalable strategies to promote active living and enhance quality of life among people with advanced cancer.
Primary Outcome
Semi-structured interviews will be used to assess participants' overall experience and their perceptions of the usability, usefulness, and enjoyability of the intervention.
Conditions Studied
Interventions
- BEHAVIORAL Acceptance- and mindfulness-based physical activity promotion
Study Locations (1)
Oklahoma
- TSET Health Promotion Research Center - Oklahoma City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2026-02-27 |
| Est. Completion | 2026-06 |
| Phase | NA |
What NCT07238023 shows while recruiting
NCT07238023 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 38 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Metastatic Invasive Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Acceptance- and mindfulness-based physical activity promotion is the first listed.
NCT07238023 reports a single indexed study location in Oklahoma.
Frequently Asked Questions
What is clinical trial NCT07238023 about?
NCT07238023 is a clinical study titled "Promoting Active Living Among People With Metastatic Breast Cancer". Individuals with metastatic breast cancer are living longer but often face persistent fatigue, functional decline, and psychological distress. Physical activity is generally safe for this population and may alleviate symptom burden. Yet, limited interventions are tailored to the unique and needs and...
What is the current status of trial NCT07238023?
This trial is currently recruiting. It is a NA study. The enrollment target is 38 participants. The study started on 2026-02-27. Estimated completion is 2026-06.
What conditions does trial NCT07238023 study?
This clinical trial studies the following conditions: Metastatic Invasive Breast Cancer.
What interventions are being tested in trial NCT07238023?
The interventions under investigation include: Acceptance- and mindfulness-based physical activity promotion (BEHAVIORAL).
Who is sponsoring clinical trial NCT07238023?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07238023 being conducted?
This trial has 1 study location across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07238023's enrollment target sits among peer trials
38 1538th of 2000 higher than 461 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01684904 · 38 participants · NA
Proton Therapy for Esophageal Cancer
- NCT03310879 · 38 participants · Phase 2
Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6
- NCT03896269 · 38 participants · Phase 1
CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
- NCT04085315 · 38 participants · Phase 1
Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI